Exploring individual fixel-based white matter abnormalities in epilepsy.

diffusion MRI epilepsy fixel-based analysis individual analysis white matter

Journal

Brain communications
ISSN: 2632-1297
Titre abrégé: Brain Commun
Pays: England
ID NLM: 101755125

Informations de publication

Date de publication:
2024
Historique:
received: 11 04 2023
revised: 02 11 2023
accepted: 21 12 2023
medline: 8 1 2024
pubmed: 8 1 2024
entrez: 8 1 2024
Statut: epublish

Résumé

Diffusion MRI has provided insight into the widespread structural connectivity changes that characterize epilepsies. Although syndrome-specific white matter abnormalities have been demonstrated, studies to date have predominantly relied on statistical comparisons between patient and control groups. For diffusion MRI techniques to be of clinical value, they should be able to detect white matter microstructural changes in individual patients. In this study, we apply an individualized approach to a technique known as fixel-based analysis, to examine fibre-tract-specific abnormalities in individuals with epilepsy. We explore the potential clinical value of this individualized fixel-based approach in epilepsy patients with differing syndromic diagnoses. Diffusion MRI data from 90 neurologically healthy control participants and 10 patients with epilepsy (temporal lobe epilepsy, progressive myoclonus epilepsy, and Dravet Syndrome, malformations of cortical development) were included in this study. Measures of fibre density and cross-section were extracted for all participants across brain white matter fixels, and mean values were computed within select tracts-of-interest. Scanner harmonized and normalized data were then used to compute Z-scores for individual patients with epilepsy. White matter abnormalities were observed in distinct patterns in individual patients with epilepsy, both at the tract and fixel level. For patients with specific epilepsy syndromes, the detected white matter abnormalities were in line with expected syndrome-specific clinical phenotypes. In patients with lesional epilepsies (e.g. hippocampal sclerosis, periventricular nodular heterotopia, and bottom-of-sulcus dysplasia), white matter abnormalities were spatially concordant with lesion location. This proof-of-principle study demonstrates the clinical potential of translating advanced diffusion MRI methodology to individual-patient-level use in epilepsy. This technique could be useful both in aiding diagnosis of specific epilepsy syndromes, and in localizing structural abnormalities, and is readily amenable to other neurological disorders. We have included code and data for this study so that individualized white matter changes can be explored robustly in larger cohorts in future work.

Identifiants

pubmed: 38187877
doi: 10.1093/braincomms/fcad352
pii: fcad352
pmc: PMC10768884
doi:

Types de publication

Journal Article

Langues

eng

Pagination

fcad352

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the Guarantors of Brain.

Déclaration de conflit d'intérêts

The authors have no competing interests to declare.

Auteurs

Remika Mito (R)

Florey Institute of Neuroscience and Mental Health, Heidelberg, Victoria 3084, Australia.
Florey Department of Neuroscience and Mental Health, University of Melbourne, Melbourne, Victoria 3010, Australia.

Mangor Pedersen (M)

Florey Institute of Neuroscience and Mental Health, Heidelberg, Victoria 3084, Australia.
Department of Psychology and Neuroscience, Auckland University of Technology (AUT), Auckland 1142, New Zealand.

Heath Pardoe (H)

Florey Institute of Neuroscience and Mental Health, Heidelberg, Victoria 3084, Australia.

Donna Parker (D)

Florey Institute of Neuroscience and Mental Health, Heidelberg, Victoria 3084, Australia.

Robert E Smith (RE)

Florey Institute of Neuroscience and Mental Health, Heidelberg, Victoria 3084, Australia.
Florey Department of Neuroscience and Mental Health, University of Melbourne, Melbourne, Victoria 3010, Australia.

Jillian Cameron (J)

Epilepsy Research Centre, Department of Medicine, University of Melbourne, Austin Health, Heidelberg, Victoria 3084, Australia.

Ingrid E Scheffer (IE)

Epilepsy Research Centre, Department of Medicine, University of Melbourne, Austin Health, Heidelberg, Victoria 3084, Australia.

Samuel F Berkovic (SF)

Epilepsy Research Centre, Department of Medicine, University of Melbourne, Austin Health, Heidelberg, Victoria 3084, Australia.

David N Vaughan (DN)

Florey Institute of Neuroscience and Mental Health, Heidelberg, Victoria 3084, Australia.
Florey Department of Neuroscience and Mental Health, University of Melbourne, Melbourne, Victoria 3010, Australia.
Department of Neurology, Austin Health, Heidelberg, Victoria 3084, Australia.

Graeme D Jackson (GD)

Florey Institute of Neuroscience and Mental Health, Heidelberg, Victoria 3084, Australia.
Florey Department of Neuroscience and Mental Health, University of Melbourne, Melbourne, Victoria 3010, Australia.
Department of Neurology, Austin Health, Heidelberg, Victoria 3084, Australia.

Classifications MeSH